VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets.

Saved in:
Bibliographic Details
Title: VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets.
Authors: Rudge JS; Regneron Pharmaceuticals, Inc., Tarrytown, New York 10591, USA., Thurston G, Davis S, Papadopoulos N, Gale N, Wiegand SJ, Yancopoulos GD
Source: Cold Spring Harbor symposia on quantitative biology [Cold Spring Harb Symp Quant Biol] 2005; Vol. 70, pp. 411-8.
Publication Type: Journal Article
Journal Info: Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 1256107 Publication Model: Print Cited Medium: Print ISSN: 0091-7451 (Print) Linking ISSN: 00917451 NLM ISO Abbreviation: Cold Spring Harb Symp Quant Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0091-7451
DOI:10.1101/sqb.2005.70.052